The global Analytical Standards Market, valued at US$1.44 billion in 2022, is forecasted to grow at a robust CAGR of 5.9%, reaching US$1.53 ...

The global Analytical Standards Market, valued at US$1.44 billion in 2022, is forecasted to grow at a robust CAGR of 5.9%, reaching US$1.53 billion in 2024 and an impressive US$2.16 billion by 2030.

The global Analytical Standards Market, valued at US$1.44 billion in 2022, is forecasted to grow at a robust CAGR of 5.9%, reaching ...

According to a new market research report titled 'Metagenomics Market Size, Share, Forecast, & Trends Analysis by Technology (Shotgun Sequencing, 16S rRNA Sequencing, Whole Genome Sequencing), Product ...

PPG (NYSE:PPG) today announced its inclusion in Newsweek’s list of Most Trustworthy Companies in America for the second ...

Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment.

A Dundee academic has been awarded a prestigious national prize for his work on neurodegenerative diseases, including ...

Lexicon Pharmaceuticals (LXRX) stock soars as the company inks a licensing deal worth up to $1B with Novo Nordisk (NVO) for ...

"If you want to be an effective leader, it starts with self-awareness," former PepsiCo General Counsel David Yawman said. "Do I understand what I stand for? What I’m great at? What triggers me into ...

Lexicon Pharmaceuticals said on Friday that Danish drugmaker Novo Nordisk has entered into a licensing deal with the company ...

Sun Pharmaceutical Industries Ltd. closed 11.47% below its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

From Phil King’s Regal Partners to Russel Pillemer’s Pengana Capital, fund managers loved vision treatment hopeful Opthea.